Search...
/
Dashboard
Charting
KPIs
Stock Screener
ETF Screener
Earnings Calendar
Events Calendar
Syndicate
Street Research
Portfolios
Alert Settings
Monte Rosa Therapeutics (GLUE) Company Statistics | The Fly
GLUE
Dark
Light
Sign up for free
Sign in
Start 7 day free trial
Resources
© 2026 The Fly Inc.
The Fly Cast
Play
Press play to listen
Dark
Light
Resources
©
Monte Rosa Therapeutics
· GLUE
Dashboard
Financials
Ratios
Transcripts
Valuation
Statistics
1.002 B
+1.62%
General
Market Cap
$1B
Enterprise Value
$955.72M
Shares Outstanding
84,480,000
Dividend
—
Employees
—
Revenue Per Employee
—
Fundamental Ratios (TTM)
Gross Margin
92.94%
Operating Margin
-633.04%
Net Profit Margin
-560.85%
FCF Margin
-248.25%
ROA
-23.15%
ROE
-43.31%
ROIC
-28.19%
Current Ratio
9.52
Debt-to-Equity
0.08
Revenue Per Employee
—
Valuation (TTM)
P/E
—
PEG
—
P/S
35.08
P/FCF
—
P/B
2.07
EV/EBITDA
-6.13
Growth
Rev 1Y
63.54%
Rev 1Y Fwd Est
-46.72%
Rev 3Y (CAGR)
—
Rev 5Y (CAGR)
—
Rev 10Y (CAGR)
—
EPS 1Y
—
EPS 1Y Fwd Est
—
EPS 3Y (CAGR)
—
EPS 5Y (CAGR)
Income Statement (TTM)
Revenue
$28.73M
Gross Margin
92.94%
Operating Expenses
$208.55M
Operating Income
-$181.85M
Net Profit
-$161.12M
Balance Sheet
—
EPS 10Y (CAGR)
—
Cash and Equivalents
$90.1M
Working Capital
$569.52M
Total Assets
$696.08M
Net Debt
-$52.12M
Total Liabilities
$211.03M
Total Equity
$487.28M
Cash Flow Statement (TTM)
Cash Flow from Operations
-$61.44M
Cash Flow from Investing
-$577.78M
Cash Flow from Financing
$689.85M
Free Cash Flow
-$71.32M
Capital Expenditures
$9.88M
